News

20 Nov 2025

PExA’s Research Instrument for Lung Cancer Detection Highlighted by Sweden’s Largest Radio News Programme

The research conducted by Professor Sandra Lindstedt and her team at Lund University, using PExA’s patented research instrument, received significant attention on Sunday in Sveriges Radio’s “Kvart i fem–Ekot” (the Quarter-to-Five News). The programme reported that the Lund researchers have identified a new and simple way to detect lung cancer, which could improve opportunities for earlier detection and thereby…

Read more
14 Nov 2025

SEK 27 million from the Swedish Cancer Society awarded to Sandra Lindstedt’s team in Lund for early detection of lung cancer

PExA congratulates Professor Sandra Lindstedt and her research group at Lund University on receiving SEK 27 million in research funding from the Swedish Cancer Society, as part of the organisation’s largest-ever initiative focused on the early detection of cancer. The project aims to develop a simple and non-invasive test for the early diagnosis of lung cancer by analysing exhaled particles. The method is…

Read more
31 Oct 2025

PExA awarded SEK 1 million from Vinnova for the next step toward lung-cancer diagnostics

PExA has been awarded SEK 1,000,000 in funding from Vinnova – Sweden’s Innovation Agency – for a project that supports the company’s strategic repositioning toward future diagnostic applications. The funding is granted within the call “Deepened collaborations with the USA, the United Kingdom and Singapore in health and life science.” The project, RAISE-lung, is carried out in…

Read more
22 Oct 2025

PExA files patent application for biomarkers enabling early detection of lung cancer

PExA AB (Spotlight: PEXA) announces that the company has filed a patent application covering protein patterns for the early detection of lung cancer, based on its proprietary non-invasive airway sampling technology. Lung cancer remains the leading cause of cancer-related death worldwide, largely because the disease is typically diagnosed too late. Earlier detection could dramatically increase the chances of…

Read more
28 Aug 2025

PExA to Exhibit at the World’s Largest Lung Cancer Congress – WCLC 2025 in Barcelona

PExA today announces that the company will participate as an exhibitor at the World Conference on Lung Cancer (WCLC) in Barcelona, September 6–9, 2025. For PExA, participating at WCLC marks an important milestone in the company’s strategic focus on lung cancer diagnostics, early detection, and treatment monitoring. WCLC is the world’s largest meeting dedicated to…

Read more

Archive

Categories